Cigna Group
Cigna Group is a U.S.-based global health company that combines health benefits and pharmacy/medical services through two core segments: Cigna Healthcare and Evernorth Health Services. It serves employers, health plans, government-related programs, and individuals with medical coverage, pharmacy benefit management, specialty pharmacy, care management, and related health solutions.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenuePharmacy benefit, specialty pharmacy, care management, and related health solutions.
Medical benefit plans and coordinated health solutions for U.S. and international customers.
Run-off and non-strategic businesses not part of the core operating segments.
Customers
Cigna sells primarily to employers, unions, third-party administrators, health plans, and government-related customers, while individuals access coverage through employer-sponsored, public exchange, Medicare-related, or individual plans. In Evernorth, the company also serves managed care organizations, insurers, providers, pharmacies, and other health-system participants that buy pharmacy and care services to improve affordability and utilization management.
Middle, select, and small employers buy medical and pharmacy benefits for employees and dependents.
Health insurers, TPAs, and managed care organizations buy PBM and care services to lower cost and improve outcomes.
Individuals buy ACA exchange, individual, and other insured products for personal coverage needs.
Multinational employers and globally mobile individuals buy international health coverage and support.
Medicare-related customers and government programs were served historically, though some businesses were sold in 2025.
Strategy
Cigna’s strategy centers on integrating pharmacy and medical capabilities to improve affordability, transparency, and health outcomes at scale. Management is also emphasizing customer growth, specialty pharmacy expansion, and affordability improvements while continuing to invest in business growth and simplifying the portfolio through divestitures of non-core assets.
Cross-selling and coordination improve customer value and deepen retention.
Specialty utilization and care management are major growth and margin drivers.
Better pricing and claims composition support competitiveness and margins.
Divestitures reduce complexity and focus capital on core health services.
Geography
Cigna operates globally, with the United States as its core market and international health activity across more than 30 markets and jurisdictions. The company’s provider network is heavily U.S.-centric, but its international operations expose it to foreign regulation, currency, and local market execution risk.
Risks
Cigna’s earnings are exposed to medical cost trend, pharmacy utilization, pricing pressure, and the ability to manage claims and provider costs accurately. The company also faces regulatory, operational, and geopolitical risks from its international footprint, plus execution risk tied to large service networks, third-party vendors, and portfolio changes.
- Medical cost inflation and utilization pressureImpact: HighLikelihood: Medium
Premiums and fees may not keep pace with higher claims and service usage.
Exposure: Cigna Healthcare
- Pricing competition and margin compressionImpact: HighLikelihood: Medium
Health plans and PBM services are competitive and can face contract repricing.
Exposure: Evernorth Health Services and Cigna Healthcare
- Operational and supply-chain disruptionImpact: HighLikelihood: Medium
Claims processing, home delivery, and pharmacy fulfillment depend on uninterrupted systems and vendors.
Exposure - Goodwill and intangible asset impairmentImpact: MediumLikelihood: Medium
Acquisitions and portfolio changes create large balance-sheet intangibles sensitive to forecast revisions.
Exposure: Reporting units and acquired businesses
- International regulatory and geopolitical exposureImpact: MediumLikelihood: Low
Foreign operations require compliance with local laws, data rules, and anti-corruption regimes.
Exposure: International Health
Accounting
Judgemental itemsAccurate forecasting of utilization and unit cost is central to reported profitability.
Impact: Affects medical care ratio and segment margins
Management uses adjusted revenues to evaluate operating performance, which differs from GAAP revenue.
Impact: Impacts comparability across periods and segments
Large acquired balances are tested against forecast cash flows and discount rates.
Impact: Could create material non-cash charges
Sold Medicare-related businesses affect segment presentation and period comparability.
Impact: Changes reported revenue and earnings mix
Similar listed companies
Publicly listed companies with a comparable business focus.
Ciena Corporation
CIEN · Telephone & Telegraph Apparatus
Ciena Corp designs and sells optical networking and automation technology used to move, route, and manage high-capacity traffic across carrier, cloud, and data center networks.
Cencora, Inc.
COR · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Cencora is a pharmaceutical sourcing and distribution company that sits between drug manufacturers and healthcare providers, moving branded, specialty,…
Centene Corporation
CNC · Hospital & Medical Service Plans
Amgen Inc
AMGN · Biological Products, (No Diagnostic Substances)
Sionna Therapeutics, Inc.
SION · Pharmaceutical Preparations
SIGA Technologies Inc
SIGA · Pharmaceutical Preparations
SIGA Technologies is a U.S.-based pharmaceutical company focused on developing and commercializing treatments for orthopoxvirus infections, centered on its…
Last updated: 24/09/2026